Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 15/20 | 0.51 |
| ▸ | TLR7 | Q9NYK1 | 15/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5144738 | 0.86 | TLR8 (0.68) | TLR8TLR7 | |
| SCHEMBL5147751 | 0.82 | TLR8 (0.47) | TLR8TLR7 | |
| SCHEMBL5146603 | 0.81 | TLR8 (0.49) | TLR8TLR7ACHEPTGES | |
| SCHEMBL5144810 | 0.81 | TLR7 (0.50) | TLR8TLR7DHFR | |
| SCHEMBL5146679 | 0.78 | PTGES (0.33) | PTGES | |
| SCHEMBL2809369 | 0.77 | TLR8 (0.44) | TLR8TLR7PTGES | |
| SCHEMBL1528112 | 0.77 | TLR8 (0.77) | TLR8TLR7 | |
| SCHEMBL23037686 | 0.76 | TLR7 (0.42) | TLR8TLR7 | |
| SCHEMBL30539819 | 0.76 | TLR7 (0.42) | TLR8TLR7 | |
| SCHEMBL5147712 | 0.76 | TLR8 (0.43) | TLR8TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070259907-A1 | ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES COMPANY | 2007-11-08 | — | — | US | disclosed |
| WO-2006093514-A2 | ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259907-A1 | ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES | IL2, TSLP, IFNG | TLR8 86/4885TLR7 39/4885ACHE 4653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.